Our History
Our milestones are a sign that we will continue tirelessly on the path to the future.
1998
ROXALL Medizin was founded in Hamburg, Germany, with extensive expertise in the field of immunotherapy.
2008
ROXALL Türkiye
was established
ROXALL Medizin expanded its operations by opening its first branch in Turkey.
2010
ROXALL was founded in Austria
ROXALL Medizin continued to grow by opening a branch in Austria. With this move, it became the ROXALL Group.
2011
ROXALL Italy was established
Italy has joined the ranks of the ROXALL Group's locations.
2017
ROXALL Spain
was established
The acquisition of the allergy research facility in Bilbao, Spain (BIAL Aristegui) has laid a solid foundation for the current situation and future growth.
Immunotherapy research has been the main focus of this facility for over 70 years.
2021
Expansion outside Europe.
Key markets: Eurasia and Latin America.
2026
We are strengthening each of our locations and continuing to grow through each of our branches.
Our goal is to continue our original R&D activities on this path toward the future and to keep developing our highly effective immunotherapies.
